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Neutralism and selectionism: a network-based reconciliation
Abstract
Neutralism and selectionism are extremes of an explanatory spectrum for understanding patterns of
molecular evolution and the emergence of evolutionary innovation. Although recent genome-scale data
from protein-coding genes argue against neutralism, molecular engineering and protein evolution data
argue that neutral mutations and mutational robustness are important for evolutionary innovation. Here I
propose a reconciliation in which neutral mutations prepare the ground for later evolutionary adaptation.
Key to this perspective is an explicit understanding of molecular phenotypes that has only become
accessible in recent years.
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Summary: Neutralism and selectionism are extremes of an explanatory spectrum for 
patterns of molecular evolution. They also have broad implications for our understanding 
of evolutionary innovation. Neutralism maintains that most mutations with appreciable 
frequency in a population convey no benefit to their carrier. Selectionism maintains that a 
large fraction of such mutations do provide a benefit. While recent genome-scale data 
from protein-coding genes argue against neutralism, molecular engineering and protein 
evolution data argue that neutral mutations and mutational robustness are important for 
evolutionary innovation. In the reconciliation proposed here, neutral mutations prepare 
the ground for later evolutionary adaptation. Key to this perspective is an explicit 
understanding of molecular phenotypes that has only become accessible in recent years. 
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Neutralism and Selectionism 
 
The tension between neutralism and selectionism is at least as old as the field of 
molecular evolution 1. Most of the historical neutralism-selectionism debate centered on 
explanations for genetic variation in populations. In this context, neutralists and 
selectionists agreed that deleterious mutations occur frequently in evolving molecules, 
but they profoundly disagreed on the relative importance of effectively neutral and 
beneficial mutations. To neutralism, beneficial mutations are rare. In the words of Motoo 
Kimura, one of neutralism’s principal proponents “…random fixation of selectively 
neutral or slightly deleterious mutations occur far more frequently in evolution than 
positive Darwinian selection of definitely advantageous mutants” 2. In contrast, according 
to selectionism, beneficial mutations are abundant. In consequence, most mutations that 
go to fixation in a population would be beneficial, or at least linked to abundantly 
occurring beneficial mutations. Selectionists such as Ernst Mayr dismiss the importance 
of neutral evolutionary change altogether 3 p 204-214. While some have pronounced 
neutralism dead 4, prominent voices persist in their support of it 5, 6. Recent and nuanced 
positions emphasize the importance of demographic details such as population sizes (Box 
1, 7).  
 Although the neutralism-selectionism debate about genetic variation has abated, 
the underlying tension persists. It has implications that go far beyond explanations of 
genetic variation. One of these regards the origin of new adaptations, evolutionary 
innovations, one of the most fundamental unsolved problems of evolutionary biology. On 
the one hand, it is possible that all such innovations arise through beneficial mutations, 
mutations that change the properties of a molecule when they first arise and that 
constitute the innovation. On the other hand, such innovations might be facilitated by 
mutations that do not affect the functions of a molecule when they first arise. The first 
perspective is a selectionist perspective, whereas the second perspective is a neutralist 
perspective. The discussion below not only makes a case for how to resolve the 
neutralism-selectionism tension, it also suggest that this tension has persisted for a reason: 
To resolve it requires a detailed understanding of molecular phenotypes that is beyond 
the reach of traditional population genetic models, and that has only become available 
recently.  
  
The mounting case against neutralism 
 
Even before genome-scale evidence became available, data based on individual genes 
and their evolution argued against neutralism. Such data came from deviations of a clock-
like rate of molecular evolution predicted by the neutral theory 8, as well as from patterns 
of nucleotide variation within and among populations4, 9, 10.  
 Genome-scale data from protein-coding regions and even from some non-coding 
DNA has strengthened the case against neutralism.  For instance,  the McDonald-
Kreitman test 8 provides evidence that between 30 and more than 90 percent of nucleotide 
changes in Drosophila and other organisms go to fixation because they are beneficial 11-21.  
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A second line of evidence comes from the relationship between the mean number 
of polymorphic differences between alleles within a species, commonly denoted as π, and 
the number d of fixed differences between genes in two species. For neutral mutations, a 
positive association between π and d should exist, because the neutral theory predicts that 
both are linearly proportional to the rate at which neutral mutations arise. In stark contrast 
to this neutralist prediction, recent genome-scale data shows that this association is 
negative 17, 22. Selectionism can readily explain this association 22: Alleles genetically 
linked to a beneficial mutations that sweeps through a population will “hitchhike” to 
fixation with this mutation, because recombination cannot decouple them rapidly enough 
from this mutation during a selective sweep 23, 24. Thus, genomic regions in which such 
selective sweeps are frequent should show decreased polymorphisms (low π). In contrast, 
abundant adaptive mutations should increase the allelic divergence d in a genomic region, 
because a rapid succession of allele substitutions driven by beneficial mutations will 
occur in such regions. The net result is that π and d should be negatively related, as in 
genome-scale data, and in contrast to the neutralist view.   
 Other patterns of molecular evolution that are more easily explained by a 
selectionist perspective include larger amounts of nucleotide polymorphisms in genomic 
regions with higher recombination rates, and the “paradox of variation”, the absence of a 
strong correlation between intrapopulation genetic diversity and population size. Some of 
these patterns are reviewed in 22. 
Genome-scale sequence data is the gold standard of comparative data, the most 
comprehensive kind of data that can speak to the neutralism-selectionism debate. That it 
strongly argues in favor of abundant beneficial mutations does not bode well for 
neutralism. However, in contrast to work focused on genotypes, analyses of molecular 
phenotypes indicate that neutral change may be important for evolutionary innovation. 
Below I will discuss these recent developments, and suggest a synthetic perspective on 
both classes of evidence. From this perspective, both the neutralist emphasis on neutral 
mutations, and the selectionist emphasis on beneficial mutations capture equally 
important aspects of biological reality.  
 
Neutrality and functional innovations in the laboratory 
   
It is useful to frame the observations I will now discuss with the concept of genotype 
networks or neutral networks (Box 2), connected sets of genotypes that share the same 
phenotype. Neutral networks are abstractions with all their limitations, but they are 
immensely useful to sharpen our intuition about molecular evolution. They have already 
helped explain observations as different as the evolution of viral antigens and new 
ribozyme functions 25-27.  
  The Hepatitis delta virus is a human pathogen with a single-stranded RNA 
genome. It encodes a ribozyme that carries out a self-cleavage reaction necessary to 
complete the viral life cycle. This ribozyme is unrelated in sequence, structure, and 
enzymatic activity from the class III self-ligating ribozyme, a synthetic ligase isolated 
from a pool of random RNA molecules 25. Despite the dramatic differences between these 
molecules, Schultes and Bartel succeeded in transforming them into one another through 
a mutational walk through sequence space that required some 40 mutations 25. 
Importantly, through most of this walk the enzymatic activity of the mutated molecule 
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does not change dramatically – evidence for the existence of a genotype network for 
enzyme activity. Halfway through this walk, a small number of only four mutations was 
sufficient to change the activity of one enzyme into that of the other. These observations 
suggest that the invariance of a phenotype in the face of many mutations facilitates the 
evolution of new ribozyme functions.    
  Several recent laboratory studies involving mutations in multiple enzymes 
highlight the importance of neutral change from a different angle 28-31. One series of 
experiments studied the evolution of new functions of the enzyme cytochrome P450, a 
member of an enzyme superfamily with a wide range of enzymatic activities. The study 
in question 28 relied on error-prone Polymerase Chain Reaction (PCR) to introduce 
multiple mutations into different variants of this enzyme. These variants differed in their 
thermodynamic stability and in their robustness to mutations. The more robust a molecule 
is, the more likely it is that mutations in it are neutral, and that they do not change the 
molecule’s structure and function 28, 32. Strikingly, the stable and more robust variants of 
cytochrome P450 more readily evolved the ability to hydrolyze new substrates, such as 
the anti-inflammatory compound naproxen. 
  A different line of evidence comes from laboratory evolution studies of the 
protein serum paraoxonase 29, 31 This enzyme is primarily a lactonase, but can also 
catalyze reactions involving a variety of other substrates, including aryl esters and 
organophosphates. Error-prone PCR mutagenesis was used in an effort to increase the 
activity of these side reactions. Surprisingly, many mutations that increase these side 
activities dramatically (101-106-fold) are neutral with respect to the primary activity. 
Similar observations were made for other enzymes, such as a bacterial phosphotriesterase 
and carbonic anhydrase II 29. In addition, some 300 paraoxonase variants that are neutral 
or close to neutral with respect to its primary activity were mutationally closer to new 
phenotypes such as thiolactonase and phosphotriesterase 31. Thus, for this protein also, 
neutral sequence changes facilitate evolutionary adaptation. 
 
Neutrality and functional innovations on evolutionary time scales 
 
 The preceding studies explored the evolution of new molecular functions on short, 
laboratory time scales. Taken together, they suggest that neutral mutations and the 
robustness of a molecule to genetic change facilitate the evolution of new functions. 
Would these observations also extrapolate to larger, evolutionary time scales? Have more 
robust molecules evolved a greater diversity of functions? The answer is yes. A recent 
study on the functional diversity of protein domains took advantage of the ability to 
estimate the robustness of a protein structure to mutations, either from its distribution of 
amino acid contacts 33, or through the amount of amino acid variation observed within the 
protein 34. Robustness is highly positively associated with the functional diversity of 
proteins, either as estimated through the diversity of enzymatic reactions catalyzed by 
enzyme families 34 (Figure 1), or through more general indicators of diversity, such as 
gene ontology functional annotations 34, 35. 
 
Protein scaffolds, gene duplications, and regulatory networks. 
 
 5
Thus, on both short and long time scales, a molecule’s ability to undergo neutral 
change facilitates the evolution of new functions in it. Observations from such systematic 
studies are supplemented by more anecdotal evidence. One such line of evidence comes 
from protein engineering, where mutagenesis creates proteins with new functions from 
existing protein scaffolds. Desirable in this process are scaffolds whose structural 
backbone is insensitive to mutations, and can thus be modified through the substitution of 
many different amino acids. One of the most successful such scaffolds is the Zn-finger 
domain 36, where a zinc ion is bound to two conserved cysteine and histidine residues, an 
interaction that stabilizes the domain’s structure. This structure is strikingly robust to 
mutations. When one replaces all but seven of its 26 amino acids by alanine the structure 
is left essentially intact 37. This robustness accounts for the great versatility of this 
domain in protein engineering, where it can be used to design proteins with a great 
variety of DNA binding activities and molecular functions 38. It is perhaps no coincidence 
that the Zn-finger domain is also the most abundant domain in the human proteome, 
where 4,500 Zn-finger domains are found in more than 500 proteins 39.  
Further anecdotal evidence comes from the role of gene duplications in 
morphological evolution. Gene duplications increase the incidence of neutral mutations 
in the duplicated genes. For example, shortly after a duplication, the ratio of amino acid 
replacement to silent nucleotide changes is greatly elevated in duplicate genes 40, 41. Gene 
and genome duplications have been associated with some of the most striking 
evolutionary innovations in life’s history, such as the diversification of the vertebrate 
body plan, the radiation of flowering plants, and the evolution of highly integrated organs, 
such as the four-chambered mammalian heart 42-45. This association, although 
circumstantial, is fully consistent with the notion that the increased potential for neutral 
change caused by gene duplication facilitates evolutionary adaptation 46.    
 Most of what we know about the relationship between neutrality and evolutionary 
adaptation comes from molecules. It is, however, worth pointing out that some of these 
principles also apply to systems on higher levels of biological organization. For example, 
computational work has shown that transcriptional regulation circuits may form extended 
neutral networks in which the phenotype – a gene expression pattern  – may be preserved 
despite extensive genetic change in regulatory interactions 47. A recent experimental 
study rewired the E. coli transcriptional regulation network 48 in close to 600 different 
ways by introducing novel regulatory interactions. The vast majority of the rewired 
networks showed no growth difference to the ancestral network in several different 
environments. Such tolerance of networks to regulatory change has also been implicated 
in the evolution of yeast mating type control. Yeast cells show two different (isogametic) 
sexes called the a and α mating types. Cells of type a and α are distinguished by the 
expression of mating-type specific genes. Distantly related yeasts regulate the expression 
of these genes in profoundly different ways. For example, in the yeast Candida albicans 
a-specific genes are expressed in a-cells by a transcriptional activator. Their unexpressed 
state in α-cells is the default state. In contrast, in the yeast Saccharomyces cerevisiae, the 
a-specific genes are expressed by default. They must be transcriptionally repressed in α-
cells. A recent study 49 showed how a series of genetic changes in transcription factors 
and regulatory regions can change this regulatory mechanism without changing the 
regulatory phenotype. Taken together, observations like these suggest that the kind of 
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neutrality that aids the evolution of new functions in molecules also occurs in regulatory 
gene networks.  
 
Neutrality and new molecular phenotypes – a population perspective  
 
All evolutionary processes occur in populations. A population perspective may thus be 
helpful to understand how neutrality may facilitate evolutionary innovation, as the above 
observations suggest. Consider, as a thought experiment, a population of molecules on a 
phenotype’s neutral network (Box 2). Call the set of molecules that are just one 
nucleotide or amino-acid change away from a population member the genotypic 
neighborhood of this population. This neighborhood contains numerous different 
genotypes, many of which have phenotypes different from those of the population’s 
members. These phenotypes comprise the range of phenotypic variation that is readily 
accessible to the population – via only one mutational change. Only a small fraction of 
these phenotypic variants may be beneficial. Populations with many different phenotypes 
in their genotype neighborhood may “discover” – through blind mutational change – 
more readily one of these beneficial variants than populations with few different 
phenotypes in their neighborhood. 
Now imagine that such a population evolves via cycles of mutation and selection. 
Mutations change individual nucleotides or amino acids. Selection confines the 
population to the genotype network associated with this phenotype. If the population is 
initially genetically homogeneous, it will spread out through the neutral network and 
become more genetically diverse. Once it has spread out, the diversity of phenotypes in 
its neighborhood will also increase, until it reaches some steady-state. How does this 
steady-state diversity depend on the average fraction of mutations in network sequences 
that are neutral? This is the key question linking the propensity to produce novel 
phenotypes with neutrality.  
 This question has recently been addressed in a computational study using RNA 
secondary structures as study phenotypes 50. RNA secondary structure is an important 
phenotype in its own right, because it is required for the biological function of many 
RNA molecules 51-53. Because computationally efficient algorithms exist to predict RNA 
secondary structure from an RNA sequence 54-56, RNA secondary structure is an 
important computational model to understand genotype-phenotype relationships 57-60. The 
study in question 50 compared evolving populations with phenotypes of different 
robustness, that is, different neutral network size and different average fraction of neutral 
mutations per population member (Box 2). Populations whose members have a robust 
RNA phenotype are genetically more diverse, and also show much greater phenotypic 
diversity in their genotype neighborhood, than populations with a less robust phenotype. 
The reason is simple (Figure 2). Individual sequences on a large neutral network have, on 
average, more neutral neighbors than sequences on a small neutral network. They will 
thus experience fewer deleterious mutations, which would cause them to be eliminated 
from the population. With fewer deaths, the population remains more diverse, and 
spreads more rapidly through the neutral network. Its genotype neighborhood contains a 
richer spectrum of different phenotype. These observations are independent of mutation 
rates or population sizes. They depend only on one thing: The neighborhood of different 
genotypes on a neutral network must contain different phenotypes, an observation that 
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holds not only for molecular phenotypes 61, 62, but also for regulatory systems 63. The core 
suggestion of  Figure 2 – that neutrality facilitates evolutionary innovation and adaptation 
– agrees with the observation that robust molecules that tolerate many neutral mutations 
more readily evolve new functions both on laboratory and evolutionary time scale.  
 
Reconciling neutralism and selectionism 
 
Selectionism is supported by patterns of genomic evolution. The importance of 
robustness and neutral change is highlighted by studies of molecular phenotypes. Figure 
3 suggests how to reconcile these observations in the form of a conceptual model 
centered on the neutral network metaphor. Consider first, for simplicity, a single 
genotype (sequence or otherwise) that undergoes random mutational change, a random 
walk on the neutral network of the phenotype it adopts. Assume that this phenotype is 
suboptimal, and that the target of the evolutionary search is a better, optimal phenotype. 
The sequence may first take several neutral mutational steps on the neutral network (I 
will focus on neutral and not deleterious change, but deleterious change may actually be 
more likely. After a deleterious mutation, one would force the walker to revert to its pre-
mutation genotype.) After some number of these steps, a phenotype-changing beneficial 
mutation may produce a new phenotype closer to the target phenotype. The random 
walker will thus hop from the first to a second neutral network. From then on, the cycle 
repeats. Some number of neutral mutations – an exploration of a current neutral network 
– would be followed by a mutation that “discovers” a new phenotype closer to the target. 
The overall scenario is similar for evolving population instead of evolving single 
genotypes. The population explores one neutral network until one of its members 
uncovers a phenotype/neutral network closer to the target, through a beneficial mutation 
that then sweeps to fixation in the population. Previously occurred mutations that paved 
the way for this sweep would “hitchhike” to fixation 9, 24.  After this sweep, the 
descendants of this successful mutant explore the neutral network until one of them finds 
a new, better phenotype, and so on. In this context, strong selectionism would demand 
that no neutral mutations would occur between phenotypic changes. Every single change 
would be either deleterious (and hence eliminated), or it would discover a new genotype 
network closer to the target phenotype. 
Let us now focus on the last mutation in a sequence of neutral steps, and on the 
beneficial mutations that follow it. Importantly, the phenotypic effect of this beneficial 
mutation may depend on the mutation(s) preceding it. Figure 4 shows a hypothetical 
example involving RNA structure phenotypes, where a first mutation (C→U at position 
30) in a sequence leaves the minimum-free energy structure of an RNA molecule 
unaffected. A second mutation (C→U at position 39) then changes this secondary 
structure. The first mutation is neutral, but the second mutation is non-neutral, e.g., it 
might be beneficial. What if these two mutations had occurred in the reverse order 
(position 39 followed by 30). The C→U mutation at position 39, in and by itself, is 
neutral (Figure 4). However, if the C→U mutation at position 30 follows this change, the 
same phenotypic change results as with the previous mutation order. In other words, if 
the sequence of mutations had been reversed, we would now call the mutation at position 
39 neutral, as opposed to beneficial. Similarly, the mutation at position 30 would now be 
beneficial, where it was previously neutral. The situation would be even more 
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complicated if we considered additional mutations that the molecule experienced earlier. 
Similar observations hold as well for neutral and deleterious mutations, or for deleterious 
and beneficial mutations. A mutation’s effect exists only in the context of the mutations 
preceding it.  
In light of this observation, one could argue that it is not sensible to speak of 
neutral, deleterious, or beneficial mutations at all, if a mutation’s effect depends on the 
genotype’s evolutionary history. However, this would be throwing the baby out with the 
bathwater. The notion of a deleterious mutation is clearly necessary in characterizing the 
causes of genetic diseases, as is the notion of a beneficial mutation to characterize 
evolutionary adaptations. However, we need to acknowledge a key limitation of these 
notions. A mutation has an effect at the time at which it arises, and this effect may change 
over time: A mutational change that was once neutral may later become beneficial (or 
deleterious) depending on other genetic changes. This view stands in stark contrast to 
how the bulk of population genetics– the quantitative theory aiming to explain biological 
evolution – represents genetic change. There, with some exceptions e.g. 9, alleles are 
labeled as unchangingly deleterious, neutral, or beneficial.   
 
Boom and bust cycles of diversity 
 
If the conceptual model from Figure 3 captures the evolutionary dynamics of biological 
systems, then three classes of predictions follow. The first is that evolutionary change 
should often occur in cycles of neutral diversity expansion and selective diversity 
contraction. RNA molecules evolving towards a target structure demonstrate this kind of 
dynamics in computational work 57. However, this dynamics has also been observed in 
sufficiently well sampled evolving populations in the wild. A case in point is the 
evolution of antigenic properties in the human influenza virus. Here, hemagglutinin, a 
viral surface glycoprotein and key viral antigen, shows punctuated and episodic evolution 
in its antigenic properties. Episodes of small genetic changes with large effect on the 
antigenic phenotype alternate with periods of time where genetic variation accumulates 
with little phenotypic change. A neutral network model can best explain these features of 
hemagglutinin evolution 26, 27. More generally, the closer an evolving population 
approaches an optimal molecular phenotype, the longer it may take – the longer the 
diversity expansion phase of a cycle –to find further phenotypic improvements 57. 
Anecdotal evidence is available from laboratory evolution studies that this holds not only 
for molecular phenotypes, but also for more complex phenotypes such as cell size 64. 
Observations like these argue against a strong selectionist perspective, where no neutral 
mutations and no phenotypic stasis should occur between phenotypic changes. 
 
Pervasive epistasis 
 
A second class of prediction is that consecutive mutations in molecules should 
show interdependent effects. The relationship between the two mutations in Figure 4 is a 
special case of epistasis, a phenomenon that geneticists have known for many decades. 
Qualitatively, epistasis is the dependency of a mutation’s effects on mutations in other 
parts of a gene or genome 65, 66 Most genetic analyses of epistasis have focused on 
mutations that are induced experimentally or that are already present in a population. 
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Until recently 67-73, the temporal aspect of epistasis I highlighted above, where past 
mutations influence the effects of future mutations, have received  less attention. 
However, this is beginning to change. A number of recent studies observe that mutational 
effects frequently change over time. For instance, a recent computational study 
demonstrated that the effects of mutations on the kind of molecular structure shown in 
Figure 4 can influence the evolutionary dynamics of RNA molecules 74. In this study, the 
authors introduced mutations with small deleterious effects on an RNA structure 
phenotype into an RNA molecule, and recorded the evolutionary trajectories of these 
changes in a finite population. Population genetic theory makes specific predictions about 
the probability that such mutations go to fixation through random genetic drift 1. 
However, the incidence of fixation was significantly higher than predicted by the theory. 
Partly responsible were secondary mutations that reversed the deleterious effects of the 
original mutation, and that turned these mutations into beneficial mutations 74, 75. This is a 
more general case of the kind of epistasis illustrated in Figure 4. Such compensatory 
mutations are also obvious from phylogenetic analyses of RNA and protein evolution. 
For instance, as many as 50% of deleterious mutations in human tRNA genes occur in 
normal tRNAs of other mammals 68. Such epistasis is also called sign epistasis, because 
the fitness effects of successive mutations have different signs (positive, neutral, or 
negative) 70, 76. Sign epistasis is frequent in fruit flies 67 or humans, where 10 percent of 
disease-causing mutations are found as wild-type variants in other mammals 69. 
Mechanistic explanations for its pervasiveness have been proposed 77-79. 
Detailed functional analyses can demonstrate the epistatic interactions of specific 
mutations. A case in point is the evolution of the mineralocorticoid and the glucocorticoid 
receptor. In humans and other tetrapods, the mineralocorticoid receptor is activated by the 
hormone aldosterone, an osmoregulatory hormone. The glucocorticoid receptor 
is activated by cortisol, a stress-response hormone. The mineralocorticoid receptor 
originated via a gene duplication from the glucocorticoid receptor. Recent studies asked 
which mutations are responsible for the cortisol-specificity of the glucocorticoid receptor 
80, 81. To this end, they reconstructed the common ancestor of both receptors, a molecule 
that responds to both aldosterone and cortisol. They then identified mutations responsible 
for the receptor specialization, mutations that reduced sensitivity to aldosterone but 
retained sensitivity to cortisol. Two mutations, Ser106Pro and Leu111Gln stood out. In 
and by itself, Ser106Pro dramatically reduced overall receptor sensitivity to both 
hormones, and Leu111Gln did not affect sensitivity. However, Leu111Gln followed by 
Ser106Pro yields a receptor that is still sensitive to cortisol but 1000-fold less sensitive to 
aldosterone 80, 82. This mutant combination is another example of the epistatic interactions 
highlighted above. Leu111Gln has little effect in and by itself, but in combination with 
another mutation it facilitates the evolution of a molecular specialization that has served 
tetrapods well for many million years. Mutation pairs with this property are not alone. 
Two other mutations exist in this receptor that, in and by themselves, affect receptor 
function little, but jointly with three further mutations confer to the glucocorticoid 
receptor its present specificity 80, 81.  
Studies like these can also help elucidate the mechanistic reasons why mutations 
with weak effects can acquire strong effects in combination with other mutants. For 
example, the above Leu111Gln change introduces a new amino acid side chain. However, 
this new side chain matters only after the Ser106Pro change, which repositions this side 
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chain. The result is that the side chain at position 111 can now form a hydrogen bond 
with a hydroxyl group of cortisol (which aldosterone lacks). The result is a cortisol-
specific interaction between protein and ligand. Another general theme, best explored for 
enzymes is this. Mutations that introduce a novel enzymatic activity often also destabilize 
the protein’s structure. Thus, mutations that precede or follow these function-changing 
mutations, and that stabilize the enzyme (but themselves do not introduce a novel activity) 
can be important for functional innovation 77-79, 83. 
 Although the vast majority of information available to study molecular evolution 
comes from molecules, it is worth pointing out that similar epistatic phenomena also exist 
on higher levels of organization. Metabolic networks are a case in point. Here, many 
individual mutations that eliminate enzyme-coding genes affect cell growth very little 84-
87. Nonetheless, pairs of mutations often have strong effects, indicating epistasis. These 
effects are not necessarily detrimental, as multiple deletions of metabolic genes can even 
lead to increased growth 88.  
 
Shifting foci of selection 
   
A third class of prediction from the model of Figure 3 is that at different points in 
time, different parts of a molecule should be subject to positive selection. This prediction 
emerges naturally from the fact that each step in the evolutionary trajectory of Figure 3 
changes a different nucleotide or amino acid.  Only some such changes – those leading to 
new phenotypes – will be subject to positive selection. Put differently, residues that are 
subject to positive selection at some time may evolve neutrally at other times. For many 
years, neither available molecular data nor phylogenetic methods were sufficiently rich to 
test such predictions. This has changed, most notably with the advent of maximum-
likelihood based phylogenetic methods that allow detection of positive selection not 
specific to both individual branches of a phylogenetic tree and individual codons in a 
protein 89-93. 
Several molecular evolution studied find patterns consistent with the above 
prediction. For example, in the influenza haemagglutinin antigen, different residues of the 
antigen are associated with different antigenic properties. Changes in these residues can 
change virulence patterns and thus viral fitness 26, 27. However, the majority of amino acid 
sites associated with changes in antigenic properties, and thus likely subject to positive 
selection, evolve neutrally in other viral lineages variation 27. Similar patterns can be 
observed in the evolution of another well-studied viral antigen, the envelope glycoprotein 
env of the human immunodeficiency virus (HIV) 93, 94. A maximum-likelihood model that 
allows individual codons to shift between a state of neutral evolution and positive 
selection detects that such shifts are frequent 93. As an example, consider the 
phylogenetic tree of Figure 5. It is based on env coding sequences from a single HIV 
positive individual, in which env sequence evolution was monitored for more than 10 
years. Different color codes correspond to different codons that are under positive 
selection at different times. It is clear that even from the point of view of individual 
codons, selection is episodic. It occurs on some branches of the tree but not on others. In 
addition, codons that are under selection along some branches evolve neutrally along 
others. In some proteins, such as cytochrome b, as many as 95% of amino acid sites may 
be subject to selection pressure that varies over time 95, 96.   
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In sum, three lines of evidence support the notion that neutral (or deleterious) 
change may alternate with beneficial change at any one position of an evolving molecule.  
These are patterns of episodic diversification among evolving molecules, pervasive 
epistatic interactions among mutations, and shifting foci of positive selection. Such an 
alternation of different kinds of change is necessary if a mutation that was neutral at the 
time of its origin is to turn into a beneficial mutation later, once other parts of the 
molecule have changed, and vice versa. This evolutionary scenario, in turn, can explain 
how neutral mutations may be crucial for functional innovation, yet need not remain 
neutral forever.  
Because the model of Figure 3 is a highly abstract representation of a complex 
real-life process, a few caveats are in order. First, we do not know whether individual 
mutations are ever exactly neutral, because we cannot measure the effect of mutations 
with very weak effects in the laboratory. However, because mutations with fitness effects 
smaller than the inverse of the effective population size 1 are invisible to selection, exact 
neutrality is not required. Even successive combinations of slightly deleterious and 
compensatory beneficial mutations may lead to effectively neutral evolutionary dynamics 
77, and large populations may facilitate such combinations 71, 97. Second, beneficial 
mutations may not occur singly, but often in bursts, where an initial mutation triggers 
opportunities for further beneficial mutations to occur. For example, only one of more 
than 10 transitions between haemagglutinin antigen clusters that share key antigenic 
properties is associated with a single amino acid substitution. Each of the other cluster 
transitions are associated with multiple substitutions 26. Nonetheless, periods of adaptive 
evolution can alternate with neutral diversification even where multiple beneficial 
mutations occur in bursts 27. Third, the model does not concern evolution in a fluctuating 
environment, where molecules may be subject to changing selection pressures 9. This 
simplification is necessary to highlight that even in a constant environment, the fitness 
effects of individual genetic changes can vary dramatically over time. Environmental 
fluctuations might contribute further to such changing fitness effects.   
 
Summary and outlook 
 
The perspective I advocate here follows from two observations. First, genotype space is 
partitioned into multiple genotype networks associated with different phenotypes. Second, 
neutral genetic change can become beneficial (or detrimental), depending on other 
changes that occur after it arose. For beneficial mutations that constitute transitions 
between genotype networks (Figure 3), the second observation emerges very naturally 
from the first. The resulting view can support the importance of neutral mutations for 
evolutionary innovation, while affirming that selection is key to explain patterns of 
observed genetic variation. It can thus reconcile neutralism and selectionism.  
This perspective is simple. Its elements have precedents in earlier work 98-101. 
Why has it thus not become firmly anchored in mainstream evolutionary thinking thirty 
years ago? A good part of the reason may be that we have only recently been able to 
thoroughly analyze molecular phenotypes. For instance, although discussions of epistasis 
have permeated the evolutionary literature for decades, the meaning of epistasis, and the 
limitations of the word neutrality become clearest in the context of molecular phenotypes, 
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such as that of Figure 4. In addition, molecular engineering experiments demonstrating 
the importance of neutral change need technology that was unavailable at the time.   
 The perspective taken here suggests two complementary research programs. The 
first regards the interconversion of neutral, beneficial, and deleterious mutations. At what 
rate does such interconversion occur? How does it depend on the molecule studied? Does 
the relative frequency of neutral versus beneficial change vary among molecules? 
Phylogenetic analysis tools to answer these questions are within reach. Second, 
laboratory evolution experiments tend to focus on mutations with large effects on 
molecules. If one wants to rapidly engineer proteins with new functions, it is the rational 
thing to do. However, as a result, such laboratory studies may be subject to an 
ascertainment bias 82: They may not detect the very mutations of weak effects that 
prepare the ground for new molecular functions. Experimental techniques that give us an 
unbiased view on these mutations are needed to assess their incidence and importance 
relative to mutations immediately subject to strong selection. These two research 
programs turn a fundamental conceptual tension into a constructive research effort. This 
effort can elucidate exactly where on the spectrum between extreme neutralism and 
extreme selectionism biological evolution unfolds.    
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Figure Captions 
 
Figure 1: Protein structures highly robust to mutations evolve greater functional 
enzymatic diversity. The horizontal axis shows, for 112 ancient protein domains, the 
length-normalized largest eigenvalue of the contact density matrix 33, which is a measure 
of the number of sequences adopting the protein’s structure, and thus also of the protein’s 
robustness to mutations. The vertical axis shows a measure D of the number of enzyme 
families associated with a protein fold. Enzyme families are distinguished through the 
substrates they use, and through structural similarities in their active sites 102. If a set of 
proteins with the same fold has k different enzymatic functions, and if pi is the frequency 
with which each function i occurs in this set, then ∑−= i ii ppD log . The data shows that 
robust domains have evolved greater functional diversity. The same is observed for other 
indicators of robustness and diversity 34, 35. Redrawn from data in 34. 
 
Figure 2: Robust phenotypes can lead to a rapid yet neutral exploration of sequence 
space. Each rectangle stands for a space of genotypes. Grey circles correspond to 
individual genotypes. A straight line links two genotypes if they can be interconverted 
through a single point mutation. The left three panels show how neutral evolution 
explores genotype space for a phenotype with low robustness. This is a phenotype with a 
small neutral network, where individual genotypes have, on average, few neutral 
neighbors. The right three panels show the same evolutionary process, but for a robust 
phenotype. (All panels contain the same number of genotypes to facilitate comparison. 
They thus do not reflect neutral network sizes.) Blue circles correspond to individual 
members of a population, and red stubs correspond to deleterious mutations that cause a 
genotype to fall off a neutral network. The upper two panels show two genetically 
identical populations with moderate genotypic diversity, where several individuals have 
the same genotype. As these populations evolve through mutation and selection confining 
them to a network, the population with the robust phenotype will spread more rapidly, 
because fewer deleterious mutations impede accumulation of genotypic diversity. This 
phenomenon is independent of population sizes or mutation rates 103. 
 
Figure 3: Cycles of neutral evolution and positive selection through traversal of 
multiple networks in adaptive evolution. Grey circles correspond to individual 
genotypes. A straight line links two genotypes if they can be interconverted through a 
single point mutation. Shown is, for simplicity, the path (thick edges) of a single 
genotype through sequence space (circles). The genotype evolves towards a hypothetical 
adaptive phenotype (not shown). In order to arrive at this phenotype, it traverses four 
different neutral networks (colored nodes; colored edges point to neighbors on the same 
network bypassed by the genotype). Within each neutral network, evolution is neutral, 
but at the transition between neutral networks, positive selection occurs.   
 
Figure 4: Mutations whose neutrality depends on the order in which they occur. The 
figure focuses on two mutations in a sequence shown together with its minimum-free 
energy secondary structure 54. They are C to U transitions at positions 30 (mutation 1) 
and 39 (mutation 2). By itself, mutation 1 is neutral, as is mutation 2. However, when 
mutation 1 is followed by mutation 2, or vice versa, a changed secondary structure results.  
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Figure 5: Positive selection acts episodically on different codons in the envelope 
protein of HIV. The phylogenetic tree shown here is based on coding regions of the env 
glycoprotein (gp120) of a single patient (patient 1 from 94) isolated at different time 
points after seroconversion, that is, after the patient became HIV-positive. The numbers 
on each branch of the tree indicate the time post-seroconversion (in months). Colors 
reflect codons that are under positive selection on different branches of this tree. They 
correspond to the colors on the molecular structure of gp120 104 shown to the left of the 
center. Specifically, six codons are highlighted whose evolution follows an episodic 
pattern. For instance, codon 291 (red) is under positive selection in a sequence isolated 51 
months post-seroconversion. (at ca. 11 o’clock on the tree), but not in any other 
sequences. Codon number 300 (green) is under positive selection in three sequences 
isolated at 61 and 66 months post-seroconversion (3 o’clock), but in no other sequences. 
Codon numbers reflect coordinates relative to the beginning of the gp120 sequence from 
104. Episodic selection was detected with a maximum-likelihood codon-based approach 93. 
Branch lengths do not reflect the amount of sequence change along each branch.  
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Box 1: Genetic drift and the importance of population size . 
 
The neutral theory of molecular evolution and its offshoots aim to predict the fate of 
neutral mutations in populations 1. This fate is influenced by genetic drift, a force of 
evolutionary change that is strongest in small populations. In any finite population, the 
frequency p of an allele fluctuates from generation to generation, because alleles get 
sampled from the previous, parental generation to form the next, offspring generation. 
Such sampling fluctuations are strongest in small populations, where the total number of 
alleles to be sampled is small. For example, in diploid organisms the variance in the 
amount of change in allele frequency from generation to generation is given by V=p(1-
p)/2N 105. The quantity N here is the effective population size, which indicates how many 
individuals actually contribute alleles to the next generation. For a variety of reasons, 
including preferential reproduction of some individuals, biased sex ratios, and population 
size fluctuations over time, the effective population size is typically smaller than the 
census population size, the actual number of individuals in the population 105. The 
expression for V above shows that in small populations allele frequency fluctuations are 
larger.  
Genetic drift affects a variety of population genetic processes. For example, a 
newly arisen neutral allele that eventually goes to fixation takes on the average 4N 
generations to do so in a diploid population 105. The fate of mutations whose selection 
coefficient s, the fitness difference to a wild-type genotype, is much smaller than 1/(4N) 
is determined by drift rather than by selection, because the generation-to-generation 
random allele frequency fluctuations are stronger than the influence of selection. Even 
mutations whose selection coefficient is greater than 1/4N can be influenced by drift. 
Specifically, weakly deleterious mutations can go to fixation, whereas weakly beneficial 
mutations can be lost, all through the influence of drift. The organization of genes into 
chromosomes adds a further layer of complication. On the one hand, if a neutral mutation 
occurs physically close to a beneficial mutation, then the neutral mutation may be rapidly 
swept to a high frequency or to fixation, if recombination does not break up its 
association with the beneficial mutation. The effects of such “hitchhiking” 24 or “genetic 
draft” 9 amount to a reduction of the effective population size experienced by alleles that 
occur in region where such selective sweeps are frequent 9. On the other hand, if a neutral 
mutation occurs close to a region where deleterious mutations segregate, the neutral 
mutation may be dragged to extinction along with the deleterious mutations. This 
phenomenon of “background selection” 106 can affect polymorphisms and time to fixation 
of neutral alleles. Because recombination rates vary substantially among organisms and 
chromosomal regions 7, 107, the impact of these phenomena on allelic variation may also 
vary. 
Effective population sizes vary by some five orders of magnitude, from values of 
104 for vertebrates to values of up to 109 for prokaryotes. Effective population sizes 
generally decrease in larger and multicellular organisms 7, Ch. 4. Many alleles whose fate 
would be dominated by selection in prokaryotes might be evolving neutrally in 
vertebrates. The consequences may be far-reaching. For example, Michael Lynch 
recently argued forcefully that the emergence of the complex genome architecture of 
higher organisms, including the rising abundance of introns and transposable elements, 
may have centrally involved the relaxation of selection caused by their smaller population 
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sizes 7.     
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Box 2: Neutral networks 
 
Consider a space of discrete macromolecular sequences (genotypes) of n monomers, such 
as RNA (4n possible genotypes) or proteins (20n genotypes). In this space, call two 
sequences immediate neighbors if they can be transformed into one another by a single 
point mutation changing only one monomer. A genotype network or neutral network 58 is 
a set of genotypes that share a common phenotype. In addition, each pair of genotypes in 
the network can be connected through a series of single point mutations that do not leave 
the network. The phenotype in question could be a molecular structure (RNA or protein 
secondary or tertiary structure) or function (enzymatic activity, binding affinity, etc). The 
exploration of such networks became possible only with the ability to characterize 
molecular phenotypes for many different genotypes, either computationally or 
experimentally. The germ of this concept originated with Maynard-Smith 108, and it was 
further developed by Schuster and collaborators 58, who showed that the neutral networks 
associated with many individual minimum free energy RNA secondary structures are vast 
and span sequence space. Neutral networks were later characterized in proteins 109-112, 
and the concept can even be applied to higher-order molecular systems, such as 
regulatory networks 47. The biological importance of this concept is underscored by 
molecular evolution studies showing that very different RNA or protein molecules and 
their intermediates can have identical structure or function. Examples include group I 
self-splicing introns and globins 111, 113-115, which have conserved structure and function 
despite great sequence diversity.       
 Because even genotypes of moderate length n can have astronomically many 
phenotypes (e.g., ~1.8n RNA secondary structures)116, 117 a sequence space is filled by a 
myriad neutral networks, each one associated with a different phenotype. These 
phenotypes have very different neutral network sizes. Some phenotypes are adopted by 
many sequences. The neutral network of such phenotypes is large, and the average 
sequence on such a large network has many neighbors that are also on the network. Other 
phenotypes are adopted by fewer sequences. Their neutral networks are smaller, and 
sequences on them have fewer neighbors that are also on the network 50, 60. The last 
property implies that the larger a phenotype’s neutral network is, the greater is the 
phenotype’s robustness to mutations that change single amino acids or nucleotides.  
 The existence of neutral networks has important implications for the evolutionary 
dynamics of populations of sequences 26, 27, 57, 118. Consider a population of sequences that 
evolves gradually towards some adaptive “target” phenotype, a phenotype that cannot be 
reached in a single mutational step from the neutral network the population currently 
resides on. Through repeated mutations, this population spreads through its current 
neutral network, a process during which its genotypic diversity increases. At some point, 
a beneficial mutation may generate a new phenotype that is closer to the target phenotype. 
The new mutant lies on a new neutral network associated with this new phenotype. As it 
sweeps through the population, genotypic diversity is reduced dramatically, until all 
genotypes in the population are descendants of the mutant. The population then begins to 
spread through the mutant’s neutral network, and its diversity increases, until a new 
beneficial mutation even closer to the target phenotype occurs. Thus, evolutionary 
adaptation in genotype spaces partitioned into neutral networks are characterized by 
cycles of exploration of a neutral network (a neutralist regime), and dramatic diversity 
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reduction as beneficial mutations “discover” new phenotypes residing on new neutral 
networks (a selectionist regime).   
 Population sizes play an important role in the evolutionary dynamics associated 
with neutral networks. On the one hand, for any given molecular system – from molecule 
to network – the neutral network associated with a given phenotype will be larger in 
small populations, because selection is less effective there (Box 1). On the other hand, in 
very large populations, an astronomical number of mutations occur per generation. This 
means not only that populations diffuse more rapidly on any given network, they may 
also be able to vault any fitness “valley” that separates two neutral networks by virtue of 
double or multiple mutations that co-occur in single individuals 71, 97. There are many 
open questions about how population size, neutral network size, mutation rates, and 
recombination rates interact and affect evolutionary dynamics.  
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